Dr Dyasi’s handling of RVF ‘completely inadequate’

Onderstepoort Biological Products (OBP’s) suspended CEO Dr Andile Dyasi would apparently have faced allegations of misconduct for the management of the 2010 Rift Valley fever (RVF) outbreak, at a September disciplinary hearing, said Solidarity SA’s Schalk de Bruin.

- Advertisement -

Dr Dyasi arrived at the hearing with his legal team, but requested that the hearing be postponed until after the October court date. The OBP board decided to continue and the hearing was concluded in Dyasi’s absence, with the outcome expected to be made public soon.Regarding the evidence of wrongdoing tabled at the hearing, the OBP board would only venture that some evidence was related to Dr Dyasi’s personal conduct and some to poor governance.

However, a source who wished to remain anonymous confirmed that one of the issues that led to Dr Dyasi’s dismissal was his handling of RVF, which the board felt “embarrassed both the OBP and the country, which has a rich history of effectively dealing with disease outbreaks”.“Under Dr Dyasi’s management, the response to the outbreak was completely inadequate,” said De Bruin.

“For example, it should never have taken so long for OBP to apply for financial assistance to purchase vaccines.” Dr Dyasi’s appeal was placed on the general roll of the labour court and is due to be heard in early October. 

- Advertisement -